Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
97.80
-0.44 (-0.45%)
At close: Jul 3, 2025, 1:00 PM
98.50
+0.70 (0.72%)
After-hours: Jul 3, 2025, 4:27 PM EDT
Insmed Market Cap
Insmed has a market cap or net worth of $18.58 billion as of July 3, 2025. Its market cap has increased by 93.22% in one year.
Market Cap
18.58B
Enterprise Value
18.68B
1-Year Change
93.22%
Ranking
Category
Stock Price
$97.80
Market Cap Chart
Since June 1, 2000, Insmed's market cap has increased from $445.50M to $18.58B, an increase of 4,069.98%. That is a compound annual growth rate of 16.02%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 3, 2025 | 17.81B | 44.22% |
Dec 31, 2024 | 12.35B | 178.59% |
Dec 29, 2023 | 4.43B | 63.79% |
Dec 30, 2022 | 2.71B | -16.06% |
Dec 31, 2021 | 3.22B | -4.92% |
Dec 31, 2020 | 3.39B | 58.95% |
Dec 31, 2019 | 2.13B | 110.95% |
Dec 31, 2018 | 1.01B | -57.65% |
Dec 29, 2017 | 2.39B | 191.73% |
Dec 30, 2016 | 818.60M | -27.02% |
Dec 31, 2015 | 1.12B | 46.00% |
Dec 31, 2014 | 768.30M | 15.55% |
Dec 31, 2013 | 664.90M | 217.07% |
Dec 31, 2012 | 209.70M | 177.01% |
Dec 30, 2011 | 75.70M | -7.91% |
Dec 31, 2010 | 82.20M | -18.05% |
Dec 31, 2009 | 100.30M | 75.35% |
Dec 31, 2008 | 57.20M | -43.08% |
Dec 31, 2007 | 100.50M | 13.95% |
Dec 29, 2006 | 88.20M | -17.72% |
Dec 30, 2005 | 107.20M | 26.86% |
Dec 31, 2004 | 84.50M | -25.88% |
Dec 31, 2003 | 114.00M | 665.10% |
Dec 31, 2002 | 14.90M | -88.15% |
Dec 31, 2001 | 125.70M | 10.94% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 699.59B |
Johnson & Johnson | 374.29B |
AbbVie | 336.94B |
Novo Nordisk | 309.43B |
UnitedHealth Group | 279.00B |
Novartis AG | 243.28B |
Abbott Laboratories | 233.33B |
AstraZeneca | 219.33B |